AMP Capital Investors’s Bioverativ Inc. Common Stock BIVV Stock Holding History

AMP Capital Investors’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-4,466	Closed	-$241K	–	1246
2017 Q4	$241K	Sell	4,466 -5,900	-57%	-$323K	﹤0.01%	1133
2017 Q3	$592K	Hold	10,366	–	–	﹤0.01%	976
2017 Q2	$625K	Buy	+10,366	New	+$590K	﹤0.01%	941

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

AMP Capital Investors's BIVV Position: Q1 2018 in Review

AMP Capital Investors sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 4,466 shares — an estimated $241K sold.

AMP Capital Investors first reported a position in BIVV in Q2 2017 and held it in 3 quarters. The position peaked at $625K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

AMP Capital Investors reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
AMP Capital Investors sold 4,466 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $241K.
AMP Capital Investors first reported a position in Bioverativ Inc. Common Stock in Q2 2017 and held it in 3 quarters.
AMP Capital Investors's Bioverativ Inc. Common Stock position peaked at $625K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on AMP Capital Investors's 13F filing for Q1 2018, filed 15 May 2018.